STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Ainos, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Taiwan Carbon Nano Technology Corporation, identified as a director of Ainos, Inc. (AIMD), reported two open-market stock sales. On 09/30/2025 the reporting person sold 1,006 shares at $3.5167 each, reducing beneficial holdings to 1,047,906 shares. On 10/01/2025 they sold 1,700 shares at $3.4633, reducing holdings to 1,046,206 shares. The filing states the shares were sold for general operating purposes. The transactions are reported as direct beneficial ownership and coded as sales.

Positive

  • None.

Negative

  • Insider sale of 2,706 shares reported on 09/30/202510/01/2025
  • Director executed direct sales, reducing holdings from 1,047,906 to 1,046,206 shares

Insights

Insider sales totaling 2,706 shares on 09/30/202510/01/2025.

The filing documents two direct open-market sales: 1,006 shares at $3.5167 and 1,700 shares at $3.4633, leaving the reporting entity with just over 1.046 million shares. The seller is identified as a director, and the transactions are reported under standard Section 16 disclosure rules.

The form’s stated reason is general operating purposes; no other motive or plan is disclosed in the filing.

Sales were small relative to total holdings but are material as disclosed insider activity.

The combined sale of 2,706 shares represents a de minimis percentage of the reported post-transaction holdings (~0.26% of the reported million-plus stake), indicating these were minor dispositions rather than large divestitures. Prices reported were $3.5167 and $3.4633.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Taiwan Carbon Nano Technology Corp

(Last) (First) (Middle)
10F-2, NO. 66, SHENGYI 5TH RD.,

(Street)
ZHUBEI CITY F5 302

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ainos, Inc. [ AIMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/30/2025 S 1,006(1) D $3.5167 1,047,906 D
Common Stock 10/01/2025 S 1,700(1) D $3.4633 1,046,206 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person sold shares of common stock for general operating purposes.
Taiwan Carbon Nano Technology Corporation By: /s/ Chun-Hsien Tsai, Chairman, Chief Executive Officer 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for Ainos, Inc. (AIMD)?

The filing reports two direct sales: 1,006 shares at $3.5167 on 09/30/2025 and 1,700 shares at $3.4633 on 10/01/2025.

Who reported the transactions on Form 4 for AIMD?

The reporting person is Taiwan Carbon Nano Technology Corporation, identified as a director of Ainos, Inc.

How many shares does the reporting person own after the transactions?

After the reported sales the filing shows beneficial ownership of 1,046,206 shares.

What reason was given for the sales in the Form 4?

The filing states the shares were sold for general operating purposes.

Were the transactions direct or indirect beneficial ownership changes?

The Form 4 reports the transactions as direct (D) beneficial ownership changes.
Ainos Inc

NASDAQ:AIMD

AIMD Rankings

AIMD Latest News

AIMD Latest SEC Filings

AIMD Stock Data

9.00M
1.94M
56.73%
0.13%
2.59%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO